Oligonucleotide Synthesis Supports the Rapid Development of Nucleic Acid Drugs
Release time:
2026-02-02
New Opportunities Brought by Nucleic Acid Therapy
With the continuous in-depth research on gene regulation and RNA therapy, nucleic acid drugs are gradually becoming an important direction in the biopharmaceutical field. As a core basic technology, Oligonucleotide Synthesis plays an irreplaceable role in the development of nucleic acid drugs.
Covering Multiple Types of Nucleic Acid Molecules
Oligonucleotide synthesis can be widely applied to the construction of ASOs, siRNAs, and other functional nucleic acid molecules, providing technical support for different therapeutic strategies. The high requirements for sequence accuracy and structural integrity necessitate a highly controllable synthesis process.
Technical Precision Determines Product Quality
In the Oligonucleotide Synthesis process, coupling efficiency, deprotection steps, and purification capabilities directly affect the purity and consistency of the final product. A stable synthesis platform is an important guarantee for promoting nucleic acid drugs from research and development to clinical application.
Continuously Expanding Application Prospects
As the commercialization of nucleic acid drugs continues to advance, oligonucleotide synthesis technology will continue to play a key role in future biomedical innovation.
Other News
De-Risking Early Phase Development
New Opportunities Brought by Nucleic Acid Therapy
With the continuous in-depth research on gene regulation and RNA therapy, nucleic acid drugs are gradually becoming an important direction in the biopharmaceutical field. As a core basic technology, Oligonucleotide Synthesis plays an irreplaceable role in the development of nucleic acid drugs.
Covering Multiple Types of Nucleic Acid Molecules
Oligonucleotide synthesis can be widely applied to the construction of ASOs, siRNAs, and other functional nucleic acid molecules, providing technical support for different therapeutic strategies. The high requirements for sequence accuracy and structural integrity necessitate a highly controllable synthesis process.
Technical Precision Determines Product Quality
In the Oligonucleotide Synthesis process, coupling efficiency, deprotection steps, and purification capabilities directly affect the purity and consistency of the final product. A stable synthesis platform is an important guarantee for promoting nucleic acid drugs from research and development to clinical application.
Continuously Expanding Application Prospects
As the commercialization of nucleic acid drugs continues to advance, oligonucleotide synthesis technology will continue to play a key role in future biomedical innovation.
2026-07-01
New Opportunities Brought by Nucleic Acid Therapy
With the continuous in-depth research on gene regulation and RNA therapy, nucleic acid drugs are gradually becoming an important direction in the biopharmaceutical field. As a core basic technology, Oligonucleotide Synthesis plays an irreplaceable role in the development of nucleic acid drugs.
Covering Multiple Types of Nucleic Acid Molecules
Oligonucleotide synthesis can be widely applied to the construction of ASOs, siRNAs, and other functional nucleic acid molecules, providing technical support for different therapeutic strategies. The high requirements for sequence accuracy and structural integrity necessitate a highly controllable synthesis process.
Technical Precision Determines Product Quality
In the Oligonucleotide Synthesis process, coupling efficiency, deprotection steps, and purification capabilities directly affect the purity and consistency of the final product. A stable synthesis platform is an important guarantee for promoting nucleic acid drugs from research and development to clinical application.
Continuously Expanding Application Prospects
As the commercialization of nucleic acid drugs continues to advance, oligonucleotide synthesis technology will continue to play a key role in future biomedical innovation.
2026-07-01
New Opportunities Brought by Nucleic Acid Therapy
With the continuous in-depth research on gene regulation and RNA therapy, nucleic acid drugs are gradually becoming an important direction in the biopharmaceutical field. As a core basic technology, Oligonucleotide Synthesis plays an irreplaceable role in the development of nucleic acid drugs.
Covering Multiple Types of Nucleic Acid Molecules
Oligonucleotide synthesis can be widely applied to the construction of ASOs, siRNAs, and other functional nucleic acid molecules, providing technical support for different therapeutic strategies. The high requirements for sequence accuracy and structural integrity necessitate a highly controllable synthesis process.
Technical Precision Determines Product Quality
In the Oligonucleotide Synthesis process, coupling efficiency, deprotection steps, and purification capabilities directly affect the purity and consistency of the final product. A stable synthesis platform is an important guarantee for promoting nucleic acid drugs from research and development to clinical application.
Continuously Expanding Application Prospects
As the commercialization of nucleic acid drugs continues to advance, oligonucleotide synthesis technology will continue to play a key role in future biomedical innovation.
2026-07-01
Business Collaboration
Innovative Drug CDMO Services
Tel: 86-576-85588039 / 86-576-85580090
E-mail: bd@jiuzhoupharma.com
Business Collaboration
Innovative Drug CDMO Services
Tel: 86-576-85588039 / 86-576-85580090
E-mail: bd@jiuzhoupharma.com
Established Business Services（API）
Tel: 86-576-88881561
E-mail: bd@jiuzhoupharma.com
